Propionic Acid

Propionic Acid

SCHEMBL4155436

CCC(=O)O.O=c1[nH]c2ccc(Br)cc2c2cc[nH]c12

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.49
PRNP P04156 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
PPARG P37231 1/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
NR2E3 Q9Y5X4 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
AR P10275 1/20 0.42
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GSK3B P49841 2/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRA3 P34903 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4160624 0.85 MPO (0.43) GSK3BGABRA1GABRA3PIM1CHEK1
Propionic Acid SCHEMBL4165125 0.85 PARP1 (0.47) CYP2C19ARHPGDMEN1KMT2A
Propionic Acid SCHEMBL4169911 0.85 GABRA1 (0.41) PIM3CYP2C9CYP2C19LMNAHPGD
Propionic Acid SCHEMBL4153840 0.84 PIM1 (0.44) NPSR1HPGDMEN1KMT2AGSK3B
Propionic Acid SCHEMBL4169905 0.84 KIF11 (0.45) HPGDMEN1KMT2ALIMK1KDM4E
Propionic Acid SCHEMBL4161694 0.84 PARP1 (0.46) CYP1A2CYP2C19ARLMNAHPGD
Propionic Acid SCHEMBL4171736 0.83 PARP1 (0.41) HPGDMEN1KMT2AGSK3BLIMK1
Propionic Acid SCHEMBL4162445 0.82 AR (0.40) CYP1A2CYP2C19HIF1AARHPGD
Propionic Acid SCHEMBL4166965 0.82 BRD4 (0.41) HPGDMEN1KMT2ABTKKDM4E
Propionic Acid SCHEMBL4159957 0.82 BRD4 (0.49) HIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PIM3 337/4885PRNP 1110/4885CYP1A2 3362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.